nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—Progesterone—uterine cancer	0.112	0.175	CbGbCtD
Fesoterodine—CYP2D6—Progesterone—uterine cancer	0.105	0.164	CbGbCtD
Fesoterodine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.101	0.158	CbGbCtD
Fesoterodine—ABCB1—Dactinomycin—uterine cancer	0.0886	0.138	CbGbCtD
Fesoterodine—CYP3A4—Progesterone—uterine cancer	0.0669	0.105	CbGbCtD
Fesoterodine—ABCB1—Etoposide—uterine cancer	0.05	0.0781	CbGbCtD
Fesoterodine—ABCB1—Doxorubicin—uterine cancer	0.0341	0.0533	CbGbCtD
Fesoterodine—CYP2D6—Doxorubicin—uterine cancer	0.0321	0.0502	CbGbCtD
Fesoterodine—CYP3A4—Etoposide—uterine cancer	0.03	0.0468	CbGbCtD
Fesoterodine—CHRM3—ureter—uterine cancer	0.0297	0.338	CbGeAlD
Fesoterodine—CHRM3—muscle of abdomen—uterine cancer	0.0214	0.244	CbGeAlD
Fesoterodine—CYP3A4—Doxorubicin—uterine cancer	0.0204	0.0319	CbGbCtD
Fesoterodine—CHRM3—exocrine gland—uterine cancer	0.00586	0.0667	CbGeAlD
Fesoterodine—CHRM5—epithelium—uterine cancer	0.00456	0.0519	CbGeAlD
Fesoterodine—Angina pectoris—Progesterone—uterine cancer	0.00253	0.00929	CcSEcCtD
Fesoterodine—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.00249	0.00917	CcSEcCtD
Fesoterodine—Abdominal discomfort—Progesterone—uterine cancer	0.00249	0.00915	CcSEcCtD
Fesoterodine—CHRM3—smooth muscle tissue—uterine cancer	0.00246	0.028	CbGeAlD
Fesoterodine—Dysuria—Progesterone—uterine cancer	0.00243	0.00892	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Progesterone—uterine cancer	0.00241	0.00887	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.00882	CcSEcCtD
Fesoterodine—CHRM3—renal system—uterine cancer	0.00236	0.0269	CbGeAlD
Fesoterodine—Infestation NOS—Progesterone—uterine cancer	0.00231	0.00851	CcSEcCtD
Fesoterodine—Infestation—Progesterone—uterine cancer	0.00231	0.00851	CcSEcCtD
Fesoterodine—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00829	CcSEcCtD
Fesoterodine—Urinary tract infection—Progesterone—uterine cancer	0.00225	0.00827	CcSEcCtD
Fesoterodine—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.00808	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Progesterone—uterine cancer	0.00219	0.00805	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00804	CcSEcCtD
Fesoterodine—CHRM1—female reproductive system—uterine cancer	0.00212	0.0241	CbGeAlD
Fesoterodine—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00771	CcSEcCtD
Fesoterodine—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00771	CcSEcCtD
Fesoterodine—Urinary tract disorder—Progesterone—uterine cancer	0.00205	0.00754	CcSEcCtD
Fesoterodine—Oedema peripheral—Progesterone—uterine cancer	0.00205	0.00752	CcSEcCtD
Fesoterodine—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00749	CcSEcCtD
Fesoterodine—Urethral disorder—Progesterone—uterine cancer	0.00204	0.00749	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00729	CcSEcCtD
Fesoterodine—Eye disorder—Progesterone—uterine cancer	0.00194	0.00714	CcSEcCtD
Fesoterodine—Cardiac disorder—Progesterone—uterine cancer	0.00193	0.00709	CcSEcCtD
Fesoterodine—CHRM3—female reproductive system—uterine cancer	0.00189	0.0216	CbGeAlD
Fesoterodine—Mediastinal disorder—Progesterone—uterine cancer	0.00187	0.00688	CcSEcCtD
Fesoterodine—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00683	CcSEcCtD
Fesoterodine—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.00682	CcSEcCtD
Fesoterodine—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.00678	CcSEcCtD
Fesoterodine—Mental disorder—Progesterone—uterine cancer	0.00182	0.00669	CcSEcCtD
Fesoterodine—Flatulence—Progesterone—uterine cancer	0.00178	0.00655	CcSEcCtD
Fesoterodine—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00647	CcSEcCtD
Fesoterodine—Back pain—Progesterone—uterine cancer	0.00175	0.00643	CcSEcCtD
Fesoterodine—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00642	CcSEcCtD
Fesoterodine—CHRM3—female gonad—uterine cancer	0.00172	0.0196	CbGeAlD
Fesoterodine—Vision blurred—Progesterone—uterine cancer	0.0017	0.00627	CcSEcCtD
Fesoterodine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00624	CcSEcCtD
Fesoterodine—Angioedema—Progesterone—uterine cancer	0.00165	0.00607	CcSEcCtD
Fesoterodine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00606	CcSEcCtD
Fesoterodine—Vertigo—Progesterone—uterine cancer	0.00162	0.00597	CcSEcCtD
Fesoterodine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00594	CcSEcCtD
Fesoterodine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.0059	CcSEcCtD
Fesoterodine—Palpitations—Progesterone—uterine cancer	0.0016	0.00588	CcSEcCtD
Fesoterodine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00583	CcSEcCtD
Fesoterodine—Cough—Progesterone—uterine cancer	0.00158	0.0058	CcSEcCtD
Fesoterodine—Chest pain—Progesterone—uterine cancer	0.00154	0.00566	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00153	0.00562	CcSEcCtD
Fesoterodine—Dry mouth—Progesterone—uterine cancer	0.00151	0.00554	CcSEcCtD
Fesoterodine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.0055	CcSEcCtD
Fesoterodine—Confusional state—Progesterone—uterine cancer	0.00149	0.00547	CcSEcCtD
Fesoterodine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00541	CcSEcCtD
Fesoterodine—Infection—Progesterone—uterine cancer	0.00147	0.00539	CcSEcCtD
Fesoterodine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00532	CcSEcCtD
Fesoterodine—Nervous system disorder—Progesterone—uterine cancer	0.00145	0.00532	CcSEcCtD
Fesoterodine—Tachycardia—Progesterone—uterine cancer	0.00144	0.0053	CcSEcCtD
Fesoterodine—Skin disorder—Progesterone—uterine cancer	0.00143	0.00527	CcSEcCtD
Fesoterodine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00513	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00509	CcSEcCtD
Fesoterodine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00502	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00135	0.00498	CcSEcCtD
Fesoterodine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00496	CcSEcCtD
Fesoterodine—Insomnia—Progesterone—uterine cancer	0.00133	0.00491	CcSEcCtD
Fesoterodine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00488	CcSEcCtD
Fesoterodine—Somnolence—Progesterone—uterine cancer	0.00131	0.00482	CcSEcCtD
Fesoterodine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00482	CcSEcCtD
Fesoterodine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.0048	CcSEcCtD
Fesoterodine—CYP3A4—renal system—uterine cancer	0.0013	0.0148	CbGeAlD
Fesoterodine—Dyspepsia—Progesterone—uterine cancer	0.0013	0.00478	CcSEcCtD
Fesoterodine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00478	CcSEcCtD
Fesoterodine—CYP2D6—renal system—uterine cancer	0.00128	0.0146	CbGeAlD
Fesoterodine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00127	0.00468	CcSEcCtD
Fesoterodine—Fatigue—Progesterone—uterine cancer	0.00127	0.00468	CcSEcCtD
Fesoterodine—ABCB1—myometrium—uterine cancer	0.00126	0.0144	CbGeAlD
Fesoterodine—Constipation—Progesterone—uterine cancer	0.00126	0.00464	CcSEcCtD
Fesoterodine—Feeling abnormal—Progesterone—uterine cancer	0.00122	0.00447	CcSEcCtD
Fesoterodine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00445	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Progesterone—uterine cancer	0.00121	0.00444	CcSEcCtD
Fesoterodine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00437	CcSEcCtD
Fesoterodine—Infestation NOS—Etoposide—uterine cancer	0.00118	0.00435	CcSEcCtD
Fesoterodine—Infestation—Etoposide—uterine cancer	0.00118	0.00435	CcSEcCtD
Fesoterodine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00433	CcSEcCtD
Fesoterodine—Urticaria—Progesterone—uterine cancer	0.00117	0.00431	CcSEcCtD
Fesoterodine—Abdominal pain—Progesterone—uterine cancer	0.00117	0.00429	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00424	CcSEcCtD
Fesoterodine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00424	CcSEcCtD
Fesoterodine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.0042	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Etoposide—uterine cancer	0.00112	0.00412	CcSEcCtD
Fesoterodine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00405	CcSEcCtD
Fesoterodine—Dry eye—Epirubicin—uterine cancer	0.0011	0.00403	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00402	CcSEcCtD
Fesoterodine—Hypersensitivity—Progesterone—uterine cancer	0.00109	0.004	CcSEcCtD
Fesoterodine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00391	CcSEcCtD
Fesoterodine—Asthenia—Progesterone—uterine cancer	0.00106	0.00389	CcSEcCtD
Fesoterodine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00389	CcSEcCtD
Fesoterodine—Urinary tract disorder—Etoposide—uterine cancer	0.00105	0.00386	CcSEcCtD
Fesoterodine—Pruritus—Progesterone—uterine cancer	0.00104	0.00384	CcSEcCtD
Fesoterodine—Urethral disorder—Etoposide—uterine cancer	0.00104	0.00383	CcSEcCtD
Fesoterodine—CYP3A4—female reproductive system—uterine cancer	0.00104	0.0118	CbGeAlD
Fesoterodine—Infection—Dactinomycin—uterine cancer	0.00104	0.00381	CcSEcCtD
Fesoterodine—CYP2D6—female reproductive system—uterine cancer	0.00102	0.0117	CbGeAlD
Fesoterodine—Dry eye—Doxorubicin—uterine cancer	0.00101	0.00373	CcSEcCtD
Fesoterodine—Diarrhoea—Progesterone—uterine cancer	0.00101	0.00371	CcSEcCtD
Fesoterodine—Eye disorder—Etoposide—uterine cancer	0.000993	0.00365	CcSEcCtD
Fesoterodine—ABCB1—epithelium—uterine cancer	0.000991	0.0113	CbGeAlD
Fesoterodine—Cardiac disorder—Etoposide—uterine cancer	0.000986	0.00363	CcSEcCtD
Fesoterodine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000985	0.00362	CcSEcCtD
Fesoterodine—ABCB1—uterine cervix—uterine cancer	0.000983	0.0112	CbGeAlD
Fesoterodine—Dizziness—Progesterone—uterine cancer	0.000976	0.00359	CcSEcCtD
Fesoterodine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000959	0.00353	CcSEcCtD
Fesoterodine—Mediastinal disorder—Etoposide—uterine cancer	0.000958	0.00352	CcSEcCtD
Fesoterodine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000946	0.00348	CcSEcCtD
Fesoterodine—ABCB1—decidua—uterine cancer	0.000937	0.0107	CbGeAlD
Fesoterodine—CYP2D6—female gonad—uterine cancer	0.000932	0.0106	CbGeAlD
Fesoterodine—Rash—Progesterone—uterine cancer	0.00093	0.00342	CcSEcCtD
Fesoterodine—Dermatitis—Progesterone—uterine cancer	0.00093	0.00342	CcSEcCtD
Fesoterodine—Headache—Progesterone—uterine cancer	0.000924	0.0034	CcSEcCtD
Fesoterodine—ABCB1—renal system—uterine cancer	0.00092	0.0105	CbGeAlD
Fesoterodine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000915	0.00336	CcSEcCtD
Fesoterodine—Dysgeusia—Etoposide—uterine cancer	0.000906	0.00333	CcSEcCtD
Fesoterodine—Fatigue—Dactinomycin—uterine cancer	0.000899	0.00331	CcSEcCtD
Fesoterodine—Back pain—Etoposide—uterine cancer	0.000895	0.00329	CcSEcCtD
Fesoterodine—ABCB1—endometrium—uterine cancer	0.000889	0.0101	CbGeAlD
Fesoterodine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000884	0.00325	CcSEcCtD
Fesoterodine—Nausea—Progesterone—uterine cancer	0.000877	0.00322	CcSEcCtD
Fesoterodine—ABCB1—mammalian vulva—uterine cancer	0.00086	0.00979	CbGeAlD
Fesoterodine—Feeling abnormal—Dactinomycin—uterine cancer	0.00086	0.00316	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000853	0.00314	CcSEcCtD
Fesoterodine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000843	0.0031	CcSEcCtD
Fesoterodine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000842	0.0031	CcSEcCtD
Fesoterodine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000838	0.00308	CcSEcCtD
Fesoterodine—Face oedema—Epirubicin—uterine cancer	0.000831	0.00306	CcSEcCtD
Fesoterodine—Vertigo—Etoposide—uterine cancer	0.000831	0.00306	CcSEcCtD
Fesoterodine—Abdominal pain—Dactinomycin—uterine cancer	0.000825	0.00303	CcSEcCtD
Fesoterodine—ABCB1—uterus—uterine cancer	0.000819	0.00933	CbGeAlD
Fesoterodine—Cough—Etoposide—uterine cancer	0.000807	0.00297	CcSEcCtD
Fesoterodine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000794	0.00292	CcSEcCtD
Fesoterodine—Dry skin—Epirubicin—uterine cancer	0.000789	0.0029	CcSEcCtD
Fesoterodine—Chest pain—Etoposide—uterine cancer	0.000787	0.0029	CcSEcCtD
Fesoterodine—Abdominal pain upper—Epirubicin—uterine cancer	0.000786	0.00289	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000782	0.00288	CcSEcCtD
Fesoterodine—Face oedema—Doxorubicin—uterine cancer	0.000769	0.00283	CcSEcCtD
Fesoterodine—Hypersensitivity—Dactinomycin—uterine cancer	0.000768	0.00283	CcSEcCtD
Fesoterodine—Confusional state—Etoposide—uterine cancer	0.000761	0.0028	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000759	0.00279	CcSEcCtD
Fesoterodine—Infection—Etoposide—uterine cancer	0.00075	0.00276	CcSEcCtD
Fesoterodine—Asthenia—Dactinomycin—uterine cancer	0.000748	0.00275	CcSEcCtD
Fesoterodine—Tachycardia—Etoposide—uterine cancer	0.000737	0.00271	CcSEcCtD
Fesoterodine—ABCB1—female reproductive system—uterine cancer	0.000737	0.00838	CbGeAlD
Fesoterodine—Skin disorder—Etoposide—uterine cancer	0.000733	0.0027	CcSEcCtD
Fesoterodine—Dry skin—Doxorubicin—uterine cancer	0.00073	0.00268	CcSEcCtD
Fesoterodine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000728	0.00268	CcSEcCtD
Fesoterodine—Angina pectoris—Epirubicin—uterine cancer	0.000725	0.00267	CcSEcCtD
Fesoterodine—Diarrhoea—Dactinomycin—uterine cancer	0.000714	0.00262	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000703	0.00258	CcSEcCtD
Fesoterodine—Dysuria—Epirubicin—uterine cancer	0.000696	0.00256	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000692	0.00254	CcSEcCtD
Fesoterodine—Somnolence—Etoposide—uterine cancer	0.000671	0.00247	CcSEcCtD
Fesoterodine—Angina pectoris—Doxorubicin—uterine cancer	0.000671	0.00247	CcSEcCtD
Fesoterodine—ABCB1—female gonad—uterine cancer	0.00067	0.00763	CbGeAlD
Fesoterodine—ABCB1—vagina—uterine cancer	0.000666	0.00758	CbGeAlD
Fesoterodine—Infestation—Epirubicin—uterine cancer	0.000663	0.00244	CcSEcCtD
Fesoterodine—Infestation NOS—Epirubicin—uterine cancer	0.000663	0.00244	CcSEcCtD
Fesoterodine—Rash—Dactinomycin—uterine cancer	0.000658	0.00242	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000652	0.0024	CcSEcCtD
Fesoterodine—Fatigue—Etoposide—uterine cancer	0.000651	0.00239	CcSEcCtD
Fesoterodine—Constipation—Etoposide—uterine cancer	0.000646	0.00237	CcSEcCtD
Fesoterodine—Urinary tract infection—Epirubicin—uterine cancer	0.000645	0.00237	CcSEcCtD
Fesoterodine—Dysuria—Doxorubicin—uterine cancer	0.000644	0.00237	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00064	0.00235	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000627	0.00231	CcSEcCtD
Fesoterodine—Feeling abnormal—Etoposide—uterine cancer	0.000622	0.00229	CcSEcCtD
Fesoterodine—Nausea—Dactinomycin—uterine cancer	0.00062	0.00228	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Etoposide—uterine cancer	0.000617	0.00227	CcSEcCtD
Fesoterodine—Infestation—Doxorubicin—uterine cancer	0.000614	0.00226	CcSEcCtD
Fesoterodine—Infestation NOS—Doxorubicin—uterine cancer	0.000614	0.00226	CcSEcCtD
Fesoterodine—Urticaria—Etoposide—uterine cancer	0.0006	0.00221	CcSEcCtD
Fesoterodine—Abdominal pain—Etoposide—uterine cancer	0.000597	0.00219	CcSEcCtD
Fesoterodine—Urinary tract infection—Doxorubicin—uterine cancer	0.000597	0.00219	CcSEcCtD
Fesoterodine—Urinary tract disorder—Epirubicin—uterine cancer	0.000588	0.00216	CcSEcCtD
Fesoterodine—Oedema peripheral—Epirubicin—uterine cancer	0.000587	0.00216	CcSEcCtD
Fesoterodine—Urethral disorder—Epirubicin—uterine cancer	0.000584	0.00215	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000581	0.00213	CcSEcCtD
Fesoterodine—Eye disorder—Epirubicin—uterine cancer	0.000557	0.00205	CcSEcCtD
Fesoterodine—Hypersensitivity—Etoposide—uterine cancer	0.000556	0.00204	CcSEcCtD
Fesoterodine—Cardiac disorder—Epirubicin—uterine cancer	0.000553	0.00203	CcSEcCtD
Fesoterodine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000544	0.002	CcSEcCtD
Fesoterodine—Oedema peripheral—Doxorubicin—uterine cancer	0.000543	0.002	CcSEcCtD
Fesoterodine—Asthenia—Etoposide—uterine cancer	0.000542	0.00199	CcSEcCtD
Fesoterodine—Urethral disorder—Doxorubicin—uterine cancer	0.00054	0.00199	CcSEcCtD
Fesoterodine—Mediastinal disorder—Epirubicin—uterine cancer	0.000537	0.00197	CcSEcCtD
Fesoterodine—Pruritus—Etoposide—uterine cancer	0.000534	0.00196	CcSEcCtD
Fesoterodine—Mental disorder—Epirubicin—uterine cancer	0.000522	0.00192	CcSEcCtD
Fesoterodine—Diarrhoea—Etoposide—uterine cancer	0.000517	0.0019	CcSEcCtD
Fesoterodine—Eye disorder—Doxorubicin—uterine cancer	0.000515	0.00189	CcSEcCtD
Fesoterodine—Cardiac disorder—Doxorubicin—uterine cancer	0.000511	0.00188	CcSEcCtD
Fesoterodine—Flatulence—Epirubicin—uterine cancer	0.000511	0.00188	CcSEcCtD
Fesoterodine—Dysgeusia—Epirubicin—uterine cancer	0.000508	0.00187	CcSEcCtD
Fesoterodine—Back pain—Epirubicin—uterine cancer	0.000502	0.00184	CcSEcCtD
Fesoterodine—Dizziness—Etoposide—uterine cancer	0.000499	0.00184	CcSEcCtD
Fesoterodine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000497	0.00183	CcSEcCtD
Fesoterodine—Vision blurred—Epirubicin—uterine cancer	0.000489	0.0018	CcSEcCtD
Fesoterodine—Mental disorder—Doxorubicin—uterine cancer	0.000483	0.00178	CcSEcCtD
Fesoterodine—Rash—Etoposide—uterine cancer	0.000476	0.00175	CcSEcCtD
Fesoterodine—Dermatitis—Etoposide—uterine cancer	0.000476	0.00175	CcSEcCtD
Fesoterodine—Headache—Etoposide—uterine cancer	0.000473	0.00174	CcSEcCtD
Fesoterodine—Flatulence—Doxorubicin—uterine cancer	0.000473	0.00174	CcSEcCtD
Fesoterodine—Dysgeusia—Doxorubicin—uterine cancer	0.00047	0.00173	CcSEcCtD
Fesoterodine—Vertigo—Epirubicin—uterine cancer	0.000466	0.00171	CcSEcCtD
Fesoterodine—Back pain—Doxorubicin—uterine cancer	0.000464	0.00171	CcSEcCtD
Fesoterodine—Palpitations—Epirubicin—uterine cancer	0.000458	0.00168	CcSEcCtD
Fesoterodine—Cough—Epirubicin—uterine cancer	0.000452	0.00166	CcSEcCtD
Fesoterodine—Vision blurred—Doxorubicin—uterine cancer	0.000452	0.00166	CcSEcCtD
Fesoterodine—Nausea—Etoposide—uterine cancer	0.000448	0.00165	CcSEcCtD
Fesoterodine—Chest pain—Epirubicin—uterine cancer	0.000441	0.00162	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000438	0.00161	CcSEcCtD
Fesoterodine—Dry mouth—Epirubicin—uterine cancer	0.000432	0.00159	CcSEcCtD
Fesoterodine—Vertigo—Doxorubicin—uterine cancer	0.000431	0.00158	CcSEcCtD
Fesoterodine—ABCB1—lymph node—uterine cancer	0.000431	0.0049	CbGeAlD
Fesoterodine—Confusional state—Epirubicin—uterine cancer	0.000427	0.00157	CcSEcCtD
Fesoterodine—Palpitations—Doxorubicin—uterine cancer	0.000424	0.00156	CcSEcCtD
Fesoterodine—Infection—Epirubicin—uterine cancer	0.00042	0.00155	CcSEcCtD
Fesoterodine—Cough—Doxorubicin—uterine cancer	0.000419	0.00154	CcSEcCtD
Fesoterodine—Nervous system disorder—Epirubicin—uterine cancer	0.000415	0.00153	CcSEcCtD
Fesoterodine—Tachycardia—Epirubicin—uterine cancer	0.000413	0.00152	CcSEcCtD
Fesoterodine—Skin disorder—Epirubicin—uterine cancer	0.000411	0.00151	CcSEcCtD
Fesoterodine—Chest pain—Doxorubicin—uterine cancer	0.000408	0.0015	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000406	0.00149	CcSEcCtD
Fesoterodine—Dry mouth—Doxorubicin—uterine cancer	0.000399	0.00147	CcSEcCtD
Fesoterodine—Confusional state—Doxorubicin—uterine cancer	0.000395	0.00145	CcSEcCtD
Fesoterodine—Infection—Doxorubicin—uterine cancer	0.000389	0.00143	CcSEcCtD
Fesoterodine—Nervous system disorder—Doxorubicin—uterine cancer	0.000384	0.00141	CcSEcCtD
Fesoterodine—Insomnia—Epirubicin—uterine cancer	0.000383	0.00141	CcSEcCtD
Fesoterodine—Tachycardia—Doxorubicin—uterine cancer	0.000382	0.00141	CcSEcCtD
Fesoterodine—Skin disorder—Doxorubicin—uterine cancer	0.00038	0.0014	CcSEcCtD
Fesoterodine—Somnolence—Epirubicin—uterine cancer	0.000376	0.00138	CcSEcCtD
Fesoterodine—Dyspepsia—Epirubicin—uterine cancer	0.000372	0.00137	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000365	0.00134	CcSEcCtD
Fesoterodine—Fatigue—Epirubicin—uterine cancer	0.000365	0.00134	CcSEcCtD
Fesoterodine—Constipation—Epirubicin—uterine cancer	0.000362	0.00133	CcSEcCtD
Fesoterodine—Insomnia—Doxorubicin—uterine cancer	0.000354	0.0013	CcSEcCtD
Fesoterodine—Feeling abnormal—Epirubicin—uterine cancer	0.000349	0.00128	CcSEcCtD
Fesoterodine—Somnolence—Doxorubicin—uterine cancer	0.000348	0.00128	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000346	0.00127	CcSEcCtD
Fesoterodine—Dyspepsia—Doxorubicin—uterine cancer	0.000345	0.00127	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000338	0.00124	CcSEcCtD
Fesoterodine—Fatigue—Doxorubicin—uterine cancer	0.000338	0.00124	CcSEcCtD
Fesoterodine—Urticaria—Epirubicin—uterine cancer	0.000336	0.00124	CcSEcCtD
Fesoterodine—Constipation—Doxorubicin—uterine cancer	0.000335	0.00123	CcSEcCtD
Fesoterodine—Abdominal pain—Epirubicin—uterine cancer	0.000335	0.00123	CcSEcCtD
Fesoterodine—Feeling abnormal—Doxorubicin—uterine cancer	0.000323	0.00119	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00032	0.00118	CcSEcCtD
Fesoterodine—Hypersensitivity—Epirubicin—uterine cancer	0.000312	0.00115	CcSEcCtD
Fesoterodine—Urticaria—Doxorubicin—uterine cancer	0.000311	0.00114	CcSEcCtD
Fesoterodine—Abdominal pain—Doxorubicin—uterine cancer	0.00031	0.00114	CcSEcCtD
Fesoterodine—Asthenia—Epirubicin—uterine cancer	0.000304	0.00112	CcSEcCtD
Fesoterodine—Pruritus—Epirubicin—uterine cancer	0.000299	0.0011	CcSEcCtD
Fesoterodine—Diarrhoea—Epirubicin—uterine cancer	0.00029	0.00106	CcSEcCtD
Fesoterodine—Hypersensitivity—Doxorubicin—uterine cancer	0.000288	0.00106	CcSEcCtD
Fesoterodine—Asthenia—Doxorubicin—uterine cancer	0.000281	0.00103	CcSEcCtD
Fesoterodine—Dizziness—Epirubicin—uterine cancer	0.00028	0.00103	CcSEcCtD
Fesoterodine—Pruritus—Doxorubicin—uterine cancer	0.000277	0.00102	CcSEcCtD
Fesoterodine—Diarrhoea—Doxorubicin—uterine cancer	0.000268	0.000985	CcSEcCtD
Fesoterodine—Rash—Epirubicin—uterine cancer	0.000267	0.000981	CcSEcCtD
Fesoterodine—Dermatitis—Epirubicin—uterine cancer	0.000267	0.00098	CcSEcCtD
Fesoterodine—Headache—Epirubicin—uterine cancer	0.000265	0.000975	CcSEcCtD
Fesoterodine—Dizziness—Doxorubicin—uterine cancer	0.000259	0.000952	CcSEcCtD
Fesoterodine—Nausea—Epirubicin—uterine cancer	0.000251	0.000924	CcSEcCtD
Fesoterodine—Rash—Doxorubicin—uterine cancer	0.000247	0.000908	CcSEcCtD
Fesoterodine—Dermatitis—Doxorubicin—uterine cancer	0.000247	0.000907	CcSEcCtD
Fesoterodine—Headache—Doxorubicin—uterine cancer	0.000245	0.000902	CcSEcCtD
Fesoterodine—Nausea—Doxorubicin—uterine cancer	0.000233	0.000855	CcSEcCtD
